Atlas Trials

A Phase III Study to Evaluate the Efficacy and Safety of Libevitug in Participants With Chronic HDV Infection (D-clear Study)

Clinical trial NCT07499544 · RECRUITING

Trial details

NCT number
NCT07499544
Sponsor
Huahui Health
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Chronic Hepatitis D Infection
Start date
2026-04-22
Primary completion
2028-09-12
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.